The JI PBL Intereron Source
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Fernald, G. H.
Right arrow Articles by Baranzini, S. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Fernald, G. H.
Right arrow Articles by Baranzini, S. E.
The Journal of Immunology, 2007, 178: 5076-5085.
Copyright © 2007 by The American Association of Immunologists, Inc.

Genome-Wide Network Analysis Reveals the Global Properties of IFN-beta Immediate Transcriptional Effects in Humans1,2

Guy Haskin Fernald*, Simon Knott{dagger}, Andrew Pachner{ddagger}, Stacy J. Caillier*, Kavitha Narayan{ddagger}, Jorge R. Oksenberg*, Parvin Mousavi{dagger} and Sergio E. Baranzini3,*

* School of Medicine, University of California, San Francisco, CA 94143; {dagger} School of Computing, Queen’s University, Kingston, Ontario, Canada; and {ddagger} University of Medicine and Dentistry of New Jersey, New Jersey Medical School, Newark, NJ 07103

IFN-beta effectively controls clinical exacerbations and magnetic resonance imaging activity in most multiple sclerosis patients. However, its mechanism of action has not been yet fully elucidated. In this study we used DNA microarrays to analyze the longitudinal transcriptional profile of blood cells within a week of IFN-beta administration. Using differential expression and gene ontology analyses we found evidence of a general decrease in the cellular activity of T lymphocytes resembling the endogenous antiviral response of IFNs. In contrast, most of the differentially expressed genes (DEGs) from untreated individuals were involved in cellular physiological processes. We then used mutual information (MI) to build networks of coregulated genes in both treated and untreated individuals. Interestingly, the connectivity distribution (k) of networks generated with high MI values displayed scale-free properties. Conversely, the observed k for networks generated with suboptimal MI values approximated a Poisson distribution, suggesting that MI captures biologically relevant interactions. Gene networks from individuals treated with IFN-beta revealed a tight core of immune- and apoptosis-related genes associated with higher values of MI. In contrast, networks obtained from untreated individuals primarily reflected cellular housekeeping functions. Finally, we trained a neural network to reverse engineer the directionality of the main interactions observed at the biological process level. This is the first study that incorporates network analysis to investigate gene regulation in response to a therapeutic drug in humans. Implications of this method in the creation of personalized models of response to therapy are discussed.

The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked advertisement in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

1 This work was funded by National Institutes of Health Grant 1R01 AI42911 and National Multiple Sclerosis Society Grant NMSS CA 1035-A-7.

2 The data presented in this article have been submitted in the Gene Expression Omnibus under accession number GSE5678.

3 Address correspondence and reprint requests to Dr. Sergio E. Baranzini, 513 Parnassus Avenue S-256, San Francisco, CA 94143. E-mail address: sebaran{at}cgl.ucsf.edu

4 Abbreviations used in this paper: MI, mutual information; DEG, differentially expressed gene; FDR, false discovery rate; GO, gene ontology; SA, sensitivity analysis; O, observed; E, expected; O/E, observed to expected (ratio); SSE, sum squared error; TMI, threshold of MI.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 2007 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 2007 by The American Association of Immunologists, Inc. All rights reserved.